Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.77 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11047247 | 0.98 | ACHE (0.75) | ACHEEPHX1EPHX2 | |
| SCHEMBL7685648 | 0.98 | ACHE (0.75) | ACHEEPHX1EPHX2 | |
| SCHEMBL7564851 | 0.96 | ACHE (0.76) | ACHEEPHX1EPHX2 | |
| SCHEMBL7689872 | 0.94 | ACHE (0.88) | ACHEEPHX1EPHX2 | |
| SCHEMBL1834619 | 0.94 | ACHE (0.74) | ACHEEPHX1EPHX2 | |
| SCHEMBL10447901 | 0.94 | ACHE (0.74) | ACHEEPHX1EPHX2 | |
| Iodide SCHEMBL25411377 | 0.92 | ACHE (0.84) | ACHEEPHX1 | |
| SCHEMBL1931371 | 0.92 | ACHE (0.85) | ACHEEPHX1EPHX2 | |
| SCHEMBL7693489 | 0.92 | ACHE (0.78) | ACHEEPHX1EPHX2 | |
| SCHEMBL13700167 | 0.92 | ACHE (0.84) | ACHEEPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220371973-A1 | Method and Molecules | MEDIMMUNE, LLC | 2022-11-24 | — | — | US | disclosed |
| CN-109641835-B | Method for producing carbamate | 国立研究开发法人产业技术综合研究所 | 2021-07-20 | — | — | CN | disclosed |
| EP-3508473-B1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | AIST (JP) | 2021-05-26 | — | — | EP | disclosed |
| US-10752579-B2 | Production method of carbamic acid ester | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2020-08-25 | — | — | US | disclosed |
| EP-3508473-A1 | METHOD FOR PRODUCING CARBAMIC ACID ESTER | National Institute of Advanced Industrial Science and Technology (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-06-20 | — | — | US | disclosed |
| WO-2013071027-A1 | MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS | ENSEMBLE THERAPEUTICS (US) | 2013-05-16 | — | — | WO | disclosed |
| US-8404650-B2 | Methods of treating cancer with doxazolidine and prodrugs thereof | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2013-03-26 | — | — | US | disclosed |
| WO-2002000622-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220371973-A1 | Method and Molecules | VIP, LNPEP, IAPP | ACHE 1623/4885EPHX1 3143/4885EPHX2 1644/4885 |
| US-20190185420-A1 | PRODUCTION METHOD OF CARBAMIC ACID ESTER | CA2, CA7, CA4 | ACHE 195/4885EPHX1 4759/4885EPHX2 2372/4885 |
| US-10752579-B2 | Production method of carbamic acid ester | CA2, CA7, CA4 | ACHE 195/4885EPHX1 4759/4885EPHX2 2372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.